About Deviation Capital
Deviation Capital is a venture capital firm founded in 2026. As of Oct 2026, Deviation Capital is an active investor, having invested in 3 companies, with 3 new investments in the last 12 months. It primarily invests in Post IPO round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series C round of Hexagon Bio Overall, Deviation Capital portfolio has seen 1 IPO, namely Bolt Biotherapeutics. A lot of funds co-invest with Deviation Capital, with names like Deep Track Capital sharing a substantial percentage of its portfolio. Deviation Capital has team of 8 people including 4 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Post IPO, Seed & 1 more
Portfolio IPOs
Portfolio Soonicorns
Deals in last 12 months
Deviation Capital's List of All Investments
Deviation Capital has a portfolio of 3 companies. Their most notable investmentis in Walden RoboticsTheir portfolio spans across and United States. They have invested in Life Sciences, High Tech, Enterprise Applications and 2 other sectors, across stages such as Post IPO, Seed and 1 more. Here is the list of all investments by Deviation Capital:1. Hexagon Bio
Provider of bioinformatics tools for the analysis of microbial genomic sequencing data. Researchers can use the platform to analyze data from microbial genome sequencing and identify small drug molecules for various therapeutic applications.
Key facts about Hexagon Bio
- Founded Year: 2017
- Location: Menlo Park (United States)
- Stage: Series C
- Total Funding till date: $268M
- Employee Count: 76 as on Sep 30, 2026
- Investors: The Column Group, Sherpalo Ventures and 11 Others
- Latest Funding Round: Series C, Oct 26, 2026, $*****
- Highlight: Editors' Pick
Developer of T-cell therapies for the treatment of cancer. The proprietary platform Boltbody immune-stimulating antibody conjugate has an approach to design anti-tumor therapeutics. The product pipeline includes BDC-3042 which is Dectin-2 agonist antibody that works by repolarizing immune cells from tumor-supportive to tumor-destructive
Key facts about Bolt Biotherapeutics
- Founded Year: 2015
- Location: Redwood City (United States)
- Annual Revenue: $1M - $10M as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $177M
- Employee Count: 42 as on Sep 30, 2026
- Investors: RA Capital Management, Curie.Bio and 19 Others
- Latest Funding Round: Post IPO, Oct 23, 2026, $*****
- Highlight: Public
Manufacturer of hardware and software for general purpose robotic systems. These robots integrate physical artificial intelligence to perform tasks such as machine tending, tool setting, parts kitting, and assembly. The systems support production workflows within manufacturing and logistics environments.
Key facts about Walden Robotics
- Stage: Seed
- Total Funding till date: $300M
- Investors: Samsung Venture Investment, Toyota and 14 Others
- Latest Funding Round: Seed, Jul 15, 2026, $*****
Deviation Capital's Year-on-Year Investment Trends
As of Oct 2026, it has made 3 investments in this year. Its most recent first time investment was in Hexagon Bio.Deviation Capital's Investments by Stage
Deviation Capital has made 1 investment in Post IPO stage with an average round size of $120M, 1 investment in Seed stage with an average round size of $300M and 1 investment in Series C stage with an average round size of $62M.Stage of entry | No. of Investments |
|---|---|
Post IPO | 1 |
Seed | 1 |
Series C | 1 |
Note: We have considered here, only first round of investments
Deviation Capital's Investments by Sector
Deviation Capital has a diverse portfolio, with companies operating in the Enterprise Applications, High Tech, Life Sciences, HealthTech and Industrial Goods and Manufacturing. Notably, it has invested in 3 Enterprise (B2B) companies, 3 Tech companies, 2 Software companies and at least 1 company focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 2 |
High Tech | 2 |
Life Sciences | 2 |
HealthTech | 1 |
Industrial Goods and Manufacturing | 1 |
Note: We have considered here, only first round of investments
Deviation Capital's Investments by Geography
Deviation Capital has made most investments in United States (2).Deviation Capital's recent investments
Deviation Capital has made 3 investments in 2026 so far. Hexagon Bio and Bolt Biotherapeutics are the latest among them.Here are the most recent investments by Deviation Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 26, 2026 | United States | Series C | 9266 | [+3] | |
Oct 23, 2026 | United States | Post IPO | 5426 | [+10] | |
Jul 15, 2026 | - | Seed | 6458 | [+14] |
IPOs and Publicly Listed companies in Deviation Capital's Portfolio
1 of Deviation Capital's portfolio company became public - Bolt Biotherapeutics. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Feb 2021 at marketcap of $690MHere are Deviation Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 05, 2021 | Oct 23, 2026 | Post IPO | 1370 |
Team profile of Deviation Capital
Deviation Capital has a team of 8 members including 4 Partners and 3 Principals located in United States. Deviation Capital's team does not sit on the board of any company as of now.Here is a list of all team members in Deviation Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | New York | - | ||
Partner | New York | - | ||
Partner | San Francisco | - | - | |
Partner | Brooklyn | - | ||
Principal | New York | - | - | |
Principal | New York City | - | - | |
Principal | San Francisco | - | - |
Co-investors of Deviation Capital
Over the past year, 42 investors have co-invested in Deviation Capital's portfolio companies. This includes only funds.
- Invested before Deviation Capital: The Column Group, Two Sigma Ventures and 14 others have invested in rounds before Deviation Capital. There is 1 company where The Column Group has invested before Deviation Capital and 1 company where Two Sigma Ventures has invested before Deviation Capital.
- Top Co-investors of Deviation Capital: 26 investors entered a company along with Deviation Capital. These include investors like Deep Track Capital (1 company).
Recent News related to Deviation Capital
•
Walden Robotics Raises $300 Million Seed Funding at $1.1 Billion ValuationSuperbCrew•Jul 16, 2026•Deviation Capital, Toyota, Nvidia
